We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Protein Blockage Causes Motor Neuron Disease

By Biotechdaily staff writers
Posted on 11 Jun 2002
Using a transgenic mouse model, researchers have shown that an accumulation of dynamitin can cause motor neuron degeneration such as that observed in amyotrophic lateral sclerosis (ALS). More...
Their study, published in the May 30, 2002, issue of Neuron, was designed to test the hypothesis that disruption of neuronal transport could account for the development of motor neuron disease.

A line of mice was engineered that overexpressed dynamitin, an element of the complex that binds and transports protein along the axons. The investigators, from the University of Pennsylvania (Philadelphia, USA), found that mice overexpressing dynamitin displayed a late-onset progressive motor neuron degenerative disease characterized by decreased strength and endurance, motor neuron degeneration and loss, and denervation of muscle.

Dynamitin overexpression was found to disassemble dynactin, a required activator of cytoplasmic dynein, resulting in an inhibition of retrograde axonal transport. "Our mouse model shows that disruption of this neuronal transport is sufficient to cause motor neuron degeneration,” explained Dr. Erika Holzbaur, who led the research team. "We hypothesize that, in humans, different insults (either inheritable or environmental) may lead to disruptions in this continuous transport process. Once it is disrupted, the health of the neuron will decline over time, resulting in the motor neuron degeneration seen in ALS.”

The investigators suggest that in light of these findings, future therapies for motor neuron diseases should seek to restore the normal flow of protein in motor neurons.



Related Links:
University of Pennsylvania

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.